Use of fomepizole as an adjunct in the treatment of acetaminophen overdose: a case series
Toxicology Communications · 01.01.2020 · 4 (1) · 1-4
DOI: 10.1080/24734306.2019.1705596 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicology Communications, online erschienen am 25.12.2019. Verfasst von Garrett Rampon und 3 weiteren Autor:innen. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acetaminophen toxicity remains a leading cause of acute liver failure in the United States and world-wide. Fomepizole is a cytochrome P450 inhibitor that may inhibit production of toxic metabolites of acetaminophen. However there are limited clinical data of its use for this purpose in the literature. Here we present a case series of six patients treated with fomepizole for acute acetaminophen toxicity who sustained no substantial liver injury.
Zitieren
APA
Rampon, G., Wartman, H., Osmon, S., & Scalzo, A. (2020). Use of fomepizole as an adjunct in the treatment of acetaminophen overdose: a case series. Toxicology Communications, 4(1), 1-4. https://doi.org/10.1080/24734306.2019.1705596
Vancouver
Rampon G, Wartman H, Osmon S, Scalzo A. Use of fomepizole as an adjunct in the treatment of acetaminophen overdose: a case series. Toxicology Communications. 2020;4(1):1-4. doi:10.1080/24734306.2019.1705596
BibTeX
@article{Rampon2020,
author = {Rampon, Garrett and Wartman, Haley and Osmon, Stephen and Scalzo, Anthony},
title = {Use of fomepizole as an adjunct in the treatment of acetaminophen overdose: a case series},
journal = {Toxicology Communications},
year = {2020},
volume = {4},
number = {1},
pages = {1--4},
doi = {10.1080/24734306.2019.1705596}
}
EUVIMED